Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

909
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

387
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Integrins01:10

Integrins

5.3K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

220
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Activation of Integrins01:15

Activation of Integrins

5.0K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.0K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

340
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific differences in the prognostic value of ischemic pre-hospital ECGs.

Frontiers in cardiovascular medicine·2026
Same author

Beyond standard therapy: clinical transdiagnostic study evaluating mindfulness-based training as an adjunct to CBT for dissociation.

Frontiers in psychiatry·2026
Same author

Multimodality assessment of aortic valve area in aortic stenosis: a multicenter validation study.

The international journal of cardiovascular imaging·2025
Same author

Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Primary and secondary metastatic dissemination: multiple routes to cancer-related death.

Molecular cancer·2025
Same author

Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.

ESMO open·2025

Related Experiment Video

Updated: Jan 21, 2026

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
05:04

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access

Published on: November 19, 2020

4.8K

Integrin ß1 polymorphisms and bleeding risk after coronary artery stenting.

M Thienel1,2, E Lüsebrink1,2, A Kastrati3,2

  • 1Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Marchioninistraße 15, 81377, Munich, Germany.

Molecular Biology Reports
|July 31, 2019
PubMed
Summary
This summary is machine-generated.

Genetic variations in beta-1 integrins do not appear to increase bleeding risk after percutaneous coronary intervention (PCI). This study found no association between specific gene variants and bleeding complications in patients undergoing PCI.

Keywords:
Bleeding riskIntegrinsPCIPolymorphismSNP rs2153875α2ß1

More Related Videos

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.2K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.3K

Related Experiment Videos

Last Updated: Jan 21, 2026

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
05:04

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access

Published on: November 19, 2020

4.8K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.2K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.3K

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Hematology

Background:

  • Bleeding complications after percutaneous coronary intervention (PCI) are linked to higher mortality.
  • The molecular mechanisms behind these bleeding events are not fully understood.
  • Platelet function, particularly integrin adhesion receptors like beta-1 (β1) integrins, is crucial for hemostasis.

Purpose of the Study:

  • To investigate the clinical impact of genetic alterations in the β1 integrin subunit on bleeding risk in patients following PCI.
  • To determine if specific genetic variations in the β1 integrin gene are associated with bleeding complications classified by TIMI or BARC criteria.

Main Methods:

  • DNA sequencing was performed on samples from 741 patients with bleeding complications after PCI, selected from a larger cohort.
  • Sanger sequencing focused on the β1 integrin cytoplasmic activation domain (exon16) and its upstream non-coding region.
  • Genotype analysis was conducted for SNP rs2153875.

Main Results:

  • Genotype variation was detected for SNP rs2153875, with allele frequencies similar to the general population.
  • No association was found between genotype variations in SNP rs2153875 and the frequency of TIMI or BARC classified bleedings.
  • Genetic variations within the β1 integrin activation domain did not correlate with increased bleeding risk post-PCI.

Conclusions:

  • Genetic alterations in the β1 integrin subunit, specifically the investigated SNP rs2153875 and variations in the activation domain, do not appear to be a significant risk factor for bleeding complications after PCI.
  • Further research may be needed to explore other molecular pathways contributing to bleeding risk in PCI patients.